A 45-Day-Old Baby, a Robot, and the Year Indian Healthcare Stopped Piloting
According to The Manila Times, in 2026, a 45-day-old infant in India underwent kidney surgery performed with a homegrown surgical robot. The same system was used to treat a cardiac patient in Sri Lanka weeks later.
This is not a press release fantasy. For most of the past five years, AI in healthcare looked like a long list of pilots, but from 2025 through 2026 that wait is over and AI has begun doing real clinical and operational work inside hospitals and diagnostic labs. Medical Buyer
The Number That Explains Everything: 64 Doctors Per 100,000 People
India does not adopt AI because it is fashionable. It adopts AI because the arithmetic of its workforce leaves no other option.
There are just 64 doctors in India for every 100,000 people, against a global average of 150. Roughly 5,500 qualified pathologists serve close to 300,000 labs, while the cancer burden crossed 1.7 million new cases in 2025.
That is why AI here is being adopted less as a productivity layer and more as a workforce extension. The pathologist-to-population ratio simply does not permit any other framing. Medical Buyer
India’s AI Healthcare Market Is Growing Faster Than Almost Anything Else in Medicine
India’s AI in healthcare market was valued at $791.2 million in 2025 and is projected to reach $4,529 million by 2030, a compound annual growth rate of 41.8%. Markets and Markets
Asia Pacific is the fastest-growing region globally at a 41.5% CAGR, with India a major contributor alongside China, Japan and South Korea. For context, the global AI in healthcare market moves from about $36.96 billion in 2025 to roughly $51.20 billion in 2026. Polaris Market ResearchPrecedence Research
Made in India: The Surgical Robot That Cost a Fraction and Crossed 12,000 Operations
The SSi Mantra, built by Gurugram-based SS Innovations, is the story most people outside medicine have missed.
It is India’s answer to systems that historically cost hospitals many crores.
As of July 6, 2026, cumulative multi-specialty procedures completed with the SSi Mantra reached 12,375, including 653 cardiac procedures, 178 telesurgeries and 225 paediatric surgeries.
Around 2,100 physicians have been trained on it, and it has been used for over 170 different procedure types. GlobeNewswireGlobeNewswire
The installed base spans 210 systems across 186 hospitals and 12 countries, covering 9 surgical specialities.
Dr Sudhir Srivastava, its founder and CEO, frames the mission as “democratizing access to state-of-the-art surgical robotic care”. SEC.govThe Manila Times
Telesurgery Went From Science Fiction to Scheduled Procedure
This is the part that should make you sit up. Indian surgeons are now operating on patients they are nowhere near.
In May 2026, an Indian doctor based in Australia performed surgery on a patient roughly 10,000 km away in Indore.
In July 2026, a kidney telesurgery was broadcast live at a major robotic surgery meeting in Florida, performed remotely from Gurugram. WikipediaGlobeNewswire
For a country where specialist surgeons cluster in six or seven metros, remote operating is not a gimmick. It is a distribution strategy.
Where Indian Hospitals Are Actually Running AI Right Now
Forget the buzzwords. Here is the live deployment map.
Apollo Hospitals has formally set aside 3.5% of its digital spend for AI and is expanding AI across all major service lines to cut documentation and routine workloads. Narayana Health is working with Google on AI imaging tools for lung disease and cardiac diagnostics. Medical BuyerMedical Buyer
Tata Memorial Hospital applies AI to predictive analytics and treatment optimisation in oncology, drawing on one of Asia’s largest cancer registries.
Medanta has AI running in both radiology and pathology, while Fortis, Max, Manipal and Aster DM have moved AI tools into clinical operations across multiple sites. Medical BuyerMedical Buyer
In February 2026, Apollo signed an MoU with Roche Diagnostics India to embed the Navify Algorithm Suite across its EMR, LIS and HIS systems for earlier detection of complex diseases. Theindianpractitioner
The Government Picked Three Referees for Healthcare AI
Regulators usually lag innovation. In India, they moved in step with it.
The Government of India has designated AIIMS Delhi, PGIMER Chandigarh and AIIMS Rishikesh as Centers of Excellence for AI in Healthcare, mandated to validate AI tools on Indian patient data, train clinicians and feed evidence back into the regulatory system. Medical Buyer
This matters more than it sounds. Models trained on Western datasets frequently underperform on Indian body habitus, disease prevalence and imaging equipment.
AI Diagnostics Are Now Cheaper Than the Old Way, and That Changes Procurement
The strongest argument for AI in Indian healthcare in 2026 is not accuracy. It is cost.
Health Technology Assessment evaluations conducted under the Government of India show a reduction of roughly ₹10,000 per TB case detected compared with existing diagnostic pathways.
The ICMR-linked assessment of qXR recorded an incremental cost-effectiveness ratio of minus 9,864.77 INR, meaning detection went up while costs went down.
Qure.ai became the first Indian AI company recommended by the World Health Organization for autonomous tuberculosis screening. Its qXR tool is deployed across 2,600-plus sites in over 67 countries. TheindianpractitionerQure AI
AI Screened for TB at the Maha Kumbh Mela
If you want one image that captures Indian healthcare AI at scale, this is it.
During the Maha Kumbh Mela, one of the world’s largest mass gatherings, AI-powered chest X-ray analysis was deployed for rapid tuberculosis surveillance in a high-density, high-risk environment. Qure.ai
Separately, research across India involving more than 5 million chest X-rays in 17 healthcare systems found AI achieved up to 98% precision in detecting abnormalities. Insightfulpost
| Layer | Player | What it does |
|---|---|---|
| Chest X-ray & CT triage | Qure.ai | TB, lung nodules, stroke |
| Blood & urine microscopy | SigTuple | Automates 70%+ of routine smears |
| Breast screening | Niramai Thermalytix | Radiation-free, no mammography needed |
| Cardiac | Tricog Health | ECG interpretation at point of care |
| Teleradiology | 5C Network | Remote reporting for Tier 2 and 3 |
SigTuple’s AI microscopy platform automates more than 70% of routine peripheral blood smear and urine samples, letting pathologists review remotely and giving smaller labs specialist-quality reporting.
Niramai’s radiation-free thermal breast screening is being used in community and primary care settings where mammography infrastructure does not reach.
Nearly Half of Indian Doctors Now Use AI Weekly, Up Threefold in a Year
Adoption curves in healthcare are famously slow. This one was not.
Industry surveys cited by the Indian School of Business in early 2026 suggest more than 40% of clinicians in India now use AI in some form in daily practice, roughly a threefold rise from the previous year.
Ambient clinical documentation, where AI listens to a consultation and drafts the note, is the most widely deployed clinical AI application, cutting EHR time by about 13 minutes per shift.
The Quiet Infrastructure Win: 84 Crore Health IDs
AI is only as good as the data plumbing beneath it. India built the plumbing first, which most countries did not.
As of January 2026, more than 84.79 crore ABHA IDs have been created and 82.69 crore health records linked, across 4.51 lakh registered health facilities and 7.61 lakh registered healthcare professionals. Hospitals integrated with ABDM report 25% faster patient registration.
eSanjeevani, the government’s AI-assisted telemedicine platform, handled more than 280 million consultations between April 2023 and November 2025.
Smart Doctor: An AI Assistant Headed for 70,000 Hospitals
The most ambitious deployment in the country is not from a private chain. It is from the state.
India’s National Health Authority is rolling out Smart Doctor, an AIIMS-built clinical decision support system, across nearly 70,000 hospitals under ABDM.
The government chose a rule-based design for this national first step specifically to sidestep the risks that come with machine learning in frontline clinical decisions. eCorpITeCorpIT
What Experts Are Actually Saying, Including the Warnings
The optimism is real. So is the caution, and the caution is coming from the people signing the cheques.
Dilip Jose, CEO of Manipal Hospitals, has argued that healthcare is emotionally sensitive, morally complex and context-heavy, making it critical for hospital chains to be mindful about where AI is embedded. His line has become the sector’s favourite quote: “The 1% error could mean a lost life.” He adds that AI should be a force multiplier inside clinical workflows, not a standalone efficiency tool. About Yashoda Hospitals +2
Prashant Warier, founder and CEO of Qure.ai, frames the mission as “making healthcare more equitable and accessible”. Dr Sangita Reddy of Apollo Hospitals has said the group’s aim is to accelerate early diagnosis, streamline workflows and improve patients’ quality of life. Medgate TodayTheindianpractitioner
The Rules Finally Arrived: CDSCO’s July 2026 Software Guidance
Until recently, AI diagnostic software in India sat in a legal grey zone. That ended this year.
On July 21, 2026, the Central Drugs Standard Control Organisation issued the final Guidance Document on Medical Device Software under the Medical Devices Rules, 2017, covering AI-enabled software, quality management systems, technical documentation and post-market surveillance. NatLawReview
The framework classifies Software as a Medical Device by risk into Classes A to D, with A and B licensed by states and C and D by CDSCO, and adds an Algorithm Change Protocol that lets manufacturers update AI models without re-licensing every change.
AI-based cancer detection tools that analyse X-rays, CT and MRI are now treated as Class C medical devices. eCorpITCourt Kutchehry
The Digital Personal Data Protection Act, 2023 treats health data as sensitive, so processing requires specific consent aligned with DPDP, the National Digital Health Mission framework and ICMR guidance. eCorpIT
Does AI in Hospitals Actually Pay for Itself?
Boards ask this before they ask anything else. The answer in 2026 is yes, with a traceable payback window.
Leading health systems report returns of around $3.20 for every dollar spent on AI within 14 months.
A 300-bed hospital processing 100,000 claims a year typically recovers between $1.8 million and $2.5 million against an annual platform cost of about $300,000 on revenue cycle automation alone. Medical BuyerMedical Buyer
Physician-led rollouts achieve adoption rates two to three times higher than IT-led rollouts, and adoption is where the return sits. Medical Buyer
People Also Ask
Which Indian hospitals use AI and robots in 2026?
Apollo, Narayana Health, Tata Memorial, Medanta, Fortis, Max Healthcare, Manipal, Aster DM, AIIMS, CMC Vellore and KMC all run AI in clinical workflows.
On robotics, the SSi Mantra alone is installed in 186 hospitals. Medical BuyerSEC.gov
Is robotic surgery in India safe?
Robotic systems do not operate autonomously. A surgeon controls every movement from a console, and the robot removes hand tremor and enables smaller incisions.
Over 12,000 procedures across 170-plus procedure types have been performed on India’s homegrown platform alone.
How much does robotic surgery cost in India?
Robotic surgery costs more than laparoscopic or open surgery, largely because of the expensive robot systems and instruments.
Indian-made platforms were built specifically to compress that premium, which is why they have spread into Tier 2 and Tier 3 cities. MedicalVault
Will AI replace doctors in India?
No, the prevailing view among Indian hospital leadership is that AI belongs inside clinical workflows as a force multiplier, not as a standalone replacement.
Given India’s doctor shortage, AI is closing a gap, not creating unemployment. cbinsights
Which is the best AI diagnostic company in India?
Qure.ai is the most internationally validated, being the first Indian AI company recommended by the WHO for autonomous TB screening.
It raised a $65 million Series D in 2026 to scale across Asia, Africa and Latin America. TheindianpractitionerAIStartupImpact
Is AI diagnosis approved by the Indian government?
Yes, under a risk-based regime. AI cancer detection software is regulated as a Class C medical device under CDSCO oversight, with mandated safety validation, quality checks and monitoring. Court Kutchehry
Can AI detect TB from a chest X-ray in India?
Yes, and it is already national policy in practice.
qXR has been evaluated by the WHO and found effective even without a human reader, and is deployed across India’s TB programme. Qure AI
What is ABHA and why does it matter for AI?
ABHA is a patient’s digital health ID under Ayushman Bharat Digital Mission.
With 84.79 crore IDs created and 82.69 crore records linked, it creates the longitudinal data layer AI models need to work well. Medical Buyer
What is AI in Indian healthcare?
AI in Indian healthcare refers to software that reads medical images, supports clinical decisions, automates documentation and assists robotic surgery across Indian hospitals and labs.
The market was worth $791.2 million in 2025 and is forecast to hit $4,529 million by 2030. Markets and Markets
How many robotic surgeries have been performed in India?
On India’s SSi Mantra platform alone, 12,375 procedures had been completed by July 2026, including 653 cardiac and 225 paediatric surgeries. GlobeNewswire
What percentage of Indian doctors use AI?
More than 40% of Indian clinicians used AI in some form in daily practice in early 2026, roughly triple the previous year.
Which AI diagnostic saves the most money in India?
AI chest X-ray screening for TB, which cuts roughly ₹10,000 per case detected versus existing diagnostic pathways.
What Comes Next, and What Still Breaks
The technology is no longer the constraint. The real limits are data readiness, workflow design, governance and the management bandwidth to drive adoption beyond early users.
Most institutions still hold fragmented, unstandardised records, and AI does not fix that on its own.
Buyers who lack a digital pathology and AI roadmap in 2026 are increasingly being told they will not make the next tender cycle.
The Bottom Line
India is not following the American AI healthcare playbook.
It is writing a cheaper, denser, more public one, driven by a workforce shortfall that no amount of medical college expansion will close this decade.
The pilot era is over, and the delivery era is harder. For patients in Indore, Raipur and Coimbatore, that shift is the difference between a diagnosis in six weeks and a diagnosis today.
Talk to our automation and AI experts
Pooja Upadhyay
Director Of People Operations & Client Relations
